Cargando…

Resistance to thyroid hormone accompanied by atrial fibrillation

Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Haruhiro, Tomita, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169536/
https://www.ncbi.nlm.nih.gov/pubmed/30306779
http://dx.doi.org/10.1530/EDM-18-0100
_version_ 1783360529891328000
author Sato, Haruhiro
Tomita, Yuichiro
author_facet Sato, Haruhiro
Tomita, Yuichiro
author_sort Sato, Haruhiro
collection PubMed
description Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillation (AF) complaining of palpitation and general fatigue. Electrocardiography results revealed AF. He exhibited elevated TH levels and an inappropriately normal level of thyroid-stimulating hormone (TSH). Despite being negative for anti-TSH receptor antibody, thyroid-stimulating antibody and anti-thyroperoxidase antibody, the patient was positive for anti-thyroglobulin (Tg) antibody. Genetic analysis of the THRB gene identified a missense mutation, F269L, leading to the diagnosis of RTH. Normal sinus rhythm was achieved after 1 week of oral bisoprolol fumarate (5 mg/day) administration. After 3 years on bisoprolol fumarate, the patient had been doing well with normal sinus rhythm, syndrome of inappropriate secretion of TSH (SITSH) and positive titer of anti-Tg antibody. LEARNING POINTS: Atrial fibrillation can occur in patients with RTH. Only a few cases have been reported on the coexistence of RTH and atrial fibrillation. No consensus exists regarding the management of atrial fibrillation in patients with RTH. Administration of bisoprolol fumarate, a beta-blocker, can ameliorate atrial fibrillation in RTH.
format Online
Article
Text
id pubmed-6169536
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-61695362018-10-10 Resistance to thyroid hormone accompanied by atrial fibrillation Sato, Haruhiro Tomita, Yuichiro Endocrinol Diabetes Metab Case Rep Insight into Disease Pathogenesis or Mechanism of Therapy Resistance to thyroid hormone (RTH), which is primarily caused by mutations in the thyroid hormone (TH) receptor beta (THRB) gene, is dominantly inherited syndrome of variable tissue hyposensitivity to TH. We herein describe a case involving a 22-year-old Japanese man with RTH and atrial fibrillation (AF) complaining of palpitation and general fatigue. Electrocardiography results revealed AF. He exhibited elevated TH levels and an inappropriately normal level of thyroid-stimulating hormone (TSH). Despite being negative for anti-TSH receptor antibody, thyroid-stimulating antibody and anti-thyroperoxidase antibody, the patient was positive for anti-thyroglobulin (Tg) antibody. Genetic analysis of the THRB gene identified a missense mutation, F269L, leading to the diagnosis of RTH. Normal sinus rhythm was achieved after 1 week of oral bisoprolol fumarate (5 mg/day) administration. After 3 years on bisoprolol fumarate, the patient had been doing well with normal sinus rhythm, syndrome of inappropriate secretion of TSH (SITSH) and positive titer of anti-Tg antibody. LEARNING POINTS: Atrial fibrillation can occur in patients with RTH. Only a few cases have been reported on the coexistence of RTH and atrial fibrillation. No consensus exists regarding the management of atrial fibrillation in patients with RTH. Administration of bisoprolol fumarate, a beta-blocker, can ameliorate atrial fibrillation in RTH. Bioscientifica Ltd 2018-10-01 /pmc/articles/PMC6169536/ /pubmed/30306779 http://dx.doi.org/10.1530/EDM-18-0100 Text en © 2018 The authors http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB) .
spellingShingle Insight into Disease Pathogenesis or Mechanism of Therapy
Sato, Haruhiro
Tomita, Yuichiro
Resistance to thyroid hormone accompanied by atrial fibrillation
title Resistance to thyroid hormone accompanied by atrial fibrillation
title_full Resistance to thyroid hormone accompanied by atrial fibrillation
title_fullStr Resistance to thyroid hormone accompanied by atrial fibrillation
title_full_unstemmed Resistance to thyroid hormone accompanied by atrial fibrillation
title_short Resistance to thyroid hormone accompanied by atrial fibrillation
title_sort resistance to thyroid hormone accompanied by atrial fibrillation
topic Insight into Disease Pathogenesis or Mechanism of Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169536/
https://www.ncbi.nlm.nih.gov/pubmed/30306779
http://dx.doi.org/10.1530/EDM-18-0100
work_keys_str_mv AT satoharuhiro resistancetothyroidhormoneaccompaniedbyatrialfibrillation
AT tomitayuichiro resistancetothyroidhormoneaccompaniedbyatrialfibrillation